In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Vascular protection - Which of your patients with chronic coronary artery disease will benefit?
Session

Congress : ESC Congress 2019

Topic : Coronary Artery Disease (Chronic)

  • Session type : Satellite Symposium
  • Date : 02 September 2019
  • Time : 13:00 - 14:00
  • Sponsored by Bayer AG

5 presentations in this session

Welcome and introduction

Congress : ESC Congress 2019

  • Session : Vascular protection - Which of your patients with chronic coronary artery disease will benefit?
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Bayer AG

Myth of stable coronary artery disease: Learnings from clinical practice

Congress : ESC Congress 2019

  • Session : Vascular protection - Which of your patients with chronic coronary artery disease will benefit?
  • Speaker : P Steg (Paris,FR)
  • Sponsored by Bayer AG

Intensified antithrombotic treatment for chronic coronary artery disease - Applying the data to your patients

Congress : ESC Congress 2019

  • Session : Vascular protection - Which of your patients with chronic coronary artery disease will benefit?
  • Speaker : J Eikelboom (Hamilton,CA)
  • Sponsored by Bayer AG

Case clinic - Treating the patient who needs more

Congress : ESC Congress 2019

  • Session : Vascular protection - Which of your patients with chronic coronary artery disease will benefit?
  • Speaker : G Montalescot (Paris,FR), R Welsh (Edmonton,CA)
  • Sponsored by Bayer AG

Questions and answers and closing remarks - Vascular protection

Congress : ESC Congress 2019

  • Session : Vascular protection - Which of your patients with chronic coronary artery disease will benefit?
  • Speaker : K Fox (Edinburgh,GB)
  • Sponsored by Bayer AG

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are